Urine biomarkers in juvenile-onset SLE nephritis

Louise Watson1, Michael W Beresford

  • 1Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Eaton Road, Liverpool L12 2AP, UK. louwatson2001@yahoo.com

Insights

Early detection of lupus nephritis (LN) in children is crucial. Promising novel biomarkers, like urinary neutrophil gelatinase associated lipocalin, may improve diagnosis and prevent kidney damage.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Biomarker Discovery

Background:

  • Juvenile-onset systemic lupus erythematosus frequently involves the kidneys, with a high risk of progression to renal failure.
  • Current markers for lupus nephritis (LN) activity are insufficient for predicting flares and guiding treatment.
  • Kidney biopsy, the gold standard, is invasive and impractical for routine monitoring in children.

Purpose of the Study:

  • To identify novel, non-invasive biomarkers for early detection and monitoring of lupus nephritis in pediatric patients.
  • To explore biomarkers that can predict disease flares and assess treatment response.
  • To overcome limitations of current diagnostic and monitoring methods for juvenile-onset LN.

Main Methods:

  • Review of current literature on biomarkers for juvenile-onset lupus nephritis.
  • Identification and evaluation of promising novel biomarkers, including urinary neutrophil gelatinase associated lipocalin, monocyte chemoattractant protein 1, and transforming growth factor-beta.
  • Discussion of the need for large-scale, prospective validation studies.

Main Results:

  • Several novel biomarkers show promise for detecting LN onset and activity.
  • No single biomarker is unique to LN, suggesting a combination approach is necessary.
  • Urinary neutrophil gelatinase associated lipocalin, monocyte chemoattractant protein 1, and transforming growth factor-beta are among the most promising candidates.

Conclusions:

  • Novel biomarkers are needed to improve the early detection and management of lupus nephritis in children.
  • A combination of biomarkers is likely required for comprehensive assessment of disease activity, treatment response, and prognosis.
  • Further validation in large pediatric cohorts is essential to establish clinical utility.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...